A new machine learning tool developed by researchers at the Queensland Institute of Medical Research Berghofer can help ...

An AI framework has been developed that analyzes multiple signals in cell-free DNA to detect cancer from blood samples. Using ...

Researchers have combined machine learning with portable biosensors to accurately detect a dangerous cyanobacterial toxin ...

Patented platform uses cell-free DNA analysis and machine learning to detect cancer early and identify tissue of origin from ...

Strand Life Sciences secures Indian patent for early cancer detection platform using cfDNA analysis from a single blood ...

Reliance's Strand Life Sciences secures Indian patent for blood-based early cancer detection technology ...

Researchers at Mayo Clinic have developed an artificial intelligence (AI) system that could transform how pancreatic cancer ...

Reliance’s Strand Life Sciences patents a blood-based technology for early cancer detection, enhancing accuracy and accessibility.

Colorectal cancer is associated with certain microbiomes that produce microbial signatures that can be detected by a ...

Portable screen-printed carbon electrode (SPCE) biosensors offer a rapid and low-cost way to detect microcystin-lysine-arginine (MC-LR), an extremely potent toxin produced by cyanobacteria during ...

Company Outlines Strategy to Position OneTest™ as the First Affordable, Multi-Cancer Early Detection Blood Test for Earlier Stage Detection ...

In a significant breakthrough for cancer diagnostics, Reliance Industries subsidiary Strand Life Sciences has secured an Indian patent for an artificial intelligence-powered technology that can detect ...